创伤性脑损伤
心理干预
精神科
人口
创伤后应激
医学
临床心理学
干预(咨询)
心理学
环境卫生
作者
Lisa A. Brenner,Kelly A. Stearns‐Yoder,Adam S. Hoffberg,Molly Penzenik,Amy J. Starosta,Theresa D. Hernández,Daniel A. Hadidi,Christopher A. Lowry
标识
DOI:10.1016/j.bbi.2017.06.003
摘要
Traumatic brain injury (TBI) is highly prevalent among a wide range of populations, including civilians, military personnel, and Veterans. TBI sequelae may be further exacerbated by symptoms associated with frequently occurring comorbid psychiatric conditions, including posttraumatic stress disorder (PTSD). This is particularly true among the population of military personnel from recent conflicts in Iraq and Afghanistan, with a history of mild TBI (mTBI) and PTSD. The need for efficacious treatments for TBI and comorbid PTSD is significant, and evidence-based interventions for these frequently co-occurring conditions are limited. Based on findings suggesting that inflammation may be an underlying mechanism of both conditions, anti-inflammatory/immunoregulatory agents, including probiotics, may represent a novel strategy to treat TBI and/or PTSD-related symptoms. The focus of this systematic review was to identify and evaluate existing research regarding prebiotic and probiotic interventions for the populations of individuals with a history of TBI and/or PTSD. Only 4 studies were identified (3 severe TBI, 1 PTSD, 0 co-occurring TBI and PTSD). Although findings suggested some promise, work in this area is nascent and results to date do not support some claims within the extensive coverage of probiotics in the popular press.
科研通智能强力驱动
Strongly Powered by AbleSci AI